Publicaciones en colaboración con investigadores/as de London School of Hygiene & Tropical Medicine (17)

2024

  1. Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial

    Clinical Infectious Diseases, Vol. 78, Núm. 3, pp. 702-710

2023

  1. Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change

    Journal of Acquired Immune Deficiency Syndromes, Vol. 93, Núm. 1, pp. 42-46

  2. First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia

    Journal of the Pediatric Infectious Diseases Society, Vol. 12, Núm. 11, pp. 581-585

  3. Genetic signature detected in T cell receptors from patients with severe COVID-19

    iScience, Vol. 26, Núm. 10

2022

  1. Empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia: study protocol for a multicenter, open-label randomized controlled clinical trial

    Trials, Vol. 23, Núm. 1

  2. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

2021

  1. Treatment of Multisystem Inflammatory Syndrome in Children

    New England Journal of Medicine, Vol. 385, Núm. 1, pp. 11-22

2020

  1. Association of pathologic complete response with long-term survival outcomes in triple-negative breast cancer: A meta-analysis

    Cancer Research, Vol. 80, Núm. 24, pp. 5427-5434

  2. Autochthonous leprosy in spain: Has the transmission of mycobacterium leprae stopped?

    PLoS Neglected Tropical Diseases, Vol. 14, Núm. 9, pp. 1-11

  3. Evaluation of pathologic complete response as a surrogate for long-term survival outcomes in triple-negative breast cancer

    JNCCN Journal of the National Comprehensive Cancer Network, Vol. 18, Núm. 8, pp. 1096-1104

2017

  1. The decline of autochthonous leprosy in the Valencia Region of Spain: Patterns and trends 1940-2015

    Leprosy Review, Vol. 88, Núm. 2, pp. 162-173

2015

  1. Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes

    New England Journal of Medicine, Vol. 373, Núm. 3, pp. 232-242

  2. Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort the PESA (Progression of Early Subclinical Atherosclerosis) study

    Circulation, Vol. 131, Núm. 24, pp. 2104-2113

2014

  1. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: Results from the Metocard-CNIC trial (Effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction)

    Journal of the American College of Cardiology, Vol. 63, Núm. 22, pp. 2356-2362

2013

  1. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction (METOCARD-CNIC) Trial

    Circulation, Vol. 128, Núm. 14, pp. 1495-1503

2009

  1. Mortality due to injuries by place of occurrence in the european region: Analysis of data quality in the WHO mortality database

    Injury Prevention, Vol. 15, Núm. 4, pp. 275-277

2007

  1. Sedentary Behaviors and the Risk of Incident Hypertension. The SUN Cohort

    American Journal of Hypertension, Vol. 20, Núm. 11, pp. 1156-1162